Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

Abstract Background Patient preferences are key parameters to evaluate benefit-harm balance of statins for primary prevention but they are not readily available to guideline developers and decision makers. Our study aimed to elicit patient preferences for benefit and harm outcomes related to use of...

Full description

Bibliographic Details
Main Authors: Henock G. Yebyo, Hélène E. Aschmann, Tsung Yu, Milo A. Puhan
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Preferences
Statins
Benefit harm outcomes
Primary prevention
Cardiovascular disease
Clinical guidelines
Online Access:http://link.springer.com/article/10.1186/s12872-018-0838-9

Internet

http://link.springer.com/article/10.1186/s12872-018-0838-9

Similar Items